CNAM spending on medicines 11.1% in 2022
Insider Insights

France: CNAM spending on medicines +11.1% in March 2022


Spending by the main health insurance fund (Caisse nationale d’assurance maladie, CNAM) on medicines increased by 11.1% in March 2022 compared to March 2021 (+18.6% over the 12 months April 2021 to March 2022 versus the previous 12 months). Expenditure on retail drugs increased 12.3% on account of increased spending on high-cost treatments and expenses linked to the COVID-19 pandemic, while spending on rétrocession drugs (ie hospital drugs which can be dispensed by hospital pharmacies to hospital out-patients and charged to the patient’s health insurer rather than the hospital) fell 0.2%.  

Spending on out-patient care rose 5.9% in March 2022 compared to March 2021. Expenditure on consultations with general practitioners (GPs) and specialists increased by 1.9% and 3.3%, respectively, over the same time period. Spending on public hospitals meanwhile grew by 17.6% in March 2022 versus March 2021 while spending on private hospitals grew 12.8%.   

Source:, “Remboursements de soins à fin mars 2022”, 26th April 2022 

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.